Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice.
Aberrant metal homeostasis may enhance the formation of reactive oxygen species and Abeta oligomerization and may therefore be a contributing factor in Alzheimer's disease. This study investigated the effect of chronic high intake of dietary Zn or Cu on brain metal levels and the accumulation and solubility of Abeta in vivo, using a transgenic mouse model that over expresses the C-terminal containing Abeta fragment of human amyloid precursor protein but does not develop amyloid deposits. Exposure to chronic high Zn or Cu in the drinking water resulted in only slight elevations of the respective metals in the brain. Total Abeta levels were unchanged although soluble Abeta levels were slightly decreased, without visible plaque formation, enhanced gliosis, antioxidant upregulation or neuronal loss. This study indicates that brain metal levels are only marginally altered by long term oral exposure to extremely high Cu or Zn levels, and that this does not induce Abeta-amyloid formation in human Abeta expressing, amyloid-free mice, although this is sufficient to modulate Abeta solubility in vivo.
Maynard
Christa J
CJ
Department of Pathology, The University of Melbourne, Melbourne, VIC, 3010, Australia.
Cappai
Roberto
R
Volitakis
Irene
I
Laughton
Katrina M
KM
Masters
Colin L
CL
Bush
Ashley I
AI
Li
Qiao-Xin
QX
D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D003300:Copper / Q000008:administration & dosage / Q000633:toxicity*; D004032:Diet; D004326:Drinking / Q000187:drug effects; D004781:Environmental Exposure; D004797:Enzyme-Linked Immunosorbent Assay; D005247:Feeding Behavior / Q000187:drug effects; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006706:Homeostasis / Q000187:drug effects*; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D008822:Mice, Transgenic; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D013312:Stress, Physiological / Q000187:drug effects; D015032:Zinc / Q000008:administration & dosage / Q000633:toxicity*
D016564:Amyloid beta-Protein Precursor; D015415:Biomarkers; D005904:Glial Fibrillary Acidic Protein; D003300:Copper; D015032:Zinc